Einträge von Zeitlinger, M. auf dem Publikationsserver

Busse, D. , Simon, P., Petroff, D., El-Najjar, N., Schmitt, L., Bindellini, D., Dietrich, A., Zeitlinger, M. , Huisinga, W. , Michelet, R. , Wrigge, H. und Kloft, C. (2022) High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients. Antimicrobial Agents and Chemotherapy 66 (6). Volltext nicht vorhanden.

Ehmann, L., Simon, P., Busse, D., Petroff, D., Dorn, Christoph , Huisinga, W., Dietrich, A., Zeitlinger, M., Wrigge, H. und Kloft, C. (2020) Risk of target non-attainment In obese compared to non-obese patients In Calculated linezolid therapy. Clinical Microbiology and Infection. Volltext nicht vorhanden.

Simon, P., Petroff, D., Dorn, Christoph , Ehmann, L., Kloft, C., Prettin, C., Dietrich, A., Zeitlinger, M., Kees, F. und Wrigge, H. (2019) Measurement of soft tissue drug concentrations in morbidly obese and non-obese patients – A prospective, parallel group, open-labeled, controlled, phase IV, single center clinical trial. Contemporary Clinical Trials Communications 15, S. 100375. Volltext nicht vorhanden.